Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Well Corporation stock logo
AMWL
American Well
$7.44
+2.1%
$7.14
$5.00
$12.95
$113.80M1.1884,390 shs12,308 shs
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
$1.94
+3.2%
$1.93
$1.29
$13.07
$70.64M-0.231.14 million shs1.66 million shs
MultiPlan Co. stock logo
MPLN
MultiPlan
$40.56
-2.2%
$29.26
$4.80
$29.84
$655.90M0.13123,727 shs103,627 shs
Phreesia, Inc. stock logo
PHR
Phreesia
$27.66
-0.8%
$25.37
$17.07
$30.53
$1.66B0.68446,551 shs455,767 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Well Corporation stock logo
AMWL
American Well
+1.85%+8.77%+0.49%-7.98%-7.12%
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
+3.19%+1.57%+31.08%-22.09%-62.76%
MultiPlan Co. stock logo
MPLN
MultiPlan
-2.24%+0.82%+52.71%+84.70%+4,055,999,900.00%
Phreesia, Inc. stock logo
PHR
Phreesia
-0.67%+7.69%+14.91%+2.10%+29.37%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Well Corporation stock logo
AMWL
American Well
3.7452 of 5 stars
4.13.00.00.02.92.51.3
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
2.6698 of 5 stars
3.61.00.00.03.12.50.6
MultiPlan Co. stock logo
MPLN
MultiPlan
N/AN/AN/AN/AN/AN/AN/AN/A
Phreesia, Inc. stock logo
PHR
Phreesia
4.0202 of 5 stars
3.51.00.04.22.42.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Well Corporation stock logo
AMWL
American Well
2.14
Hold$9.6729.93% Upside
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
3.18
Buy$21.401,003.09% Upside
MultiPlan Co. stock logo
MPLN
MultiPlan
2.00
Hold$26.25-35.28% Downside
Phreesia, Inc. stock logo
PHR
Phreesia
3.00
Buy$31.6414.38% Upside

Current Analyst Ratings Breakdown

Latest MPLN, PHR, AMWL, and BMEA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00
6/13/2025
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00
6/3/2025
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$7.00
6/2/2025
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/29/2025
Phreesia, Inc. stock logo
PHR
Phreesia
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$34.00 ➝ $35.00
5/29/2025
Phreesia, Inc. stock logo
PHR
Phreesia
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$35.00 ➝ $34.00
5/28/2025
Phreesia, Inc. stock logo
PHR
Phreesia
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/23/2025
American Well Corporation stock logo
AMWL
American Well
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$10.00 ➝ $8.00
5/15/2025
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
5/8/2025
American Well Corporation stock logo
AMWL
American Well
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$12.00 ➝ $9.00
5/6/2025
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$40.00 ➝ $18.00
(Data available from 6/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Well Corporation stock logo
AMWL
American Well
$254.36M0.46N/AN/A$20.31 per share0.37
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
N/AN/AN/AN/A$1.42 per shareN/A
MultiPlan Co. stock logo
MPLN
MultiPlan
$930.62M0.70$24.73 per share1.64$105.45 per share0.38
Phreesia, Inc. stock logo
PHR
Phreesia
$419.81M3.92N/AN/A$4.74 per share5.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Well Corporation stock logo
AMWL
American Well
-$208.14M-$10.19N/AN/AN/A-59.13%-48.36%-35.36%7/30/2025 (Estimated)
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
-$138.43M-$3.55N/AN/AN/AN/A-197.71%-134.84%7/30/2025 (Estimated)
MultiPlan Co. stock logo
MPLN
MultiPlan
-$91.70M-$101.54N/AN/AN/A-163.30%-12.14%-1.84%N/A
Phreesia, Inc. stock logo
PHR
Phreesia
-$58.53M-$0.74N/AN/AN/A-9.83%-16.23%-11.19%9/3/2025 (Estimated)

Latest MPLN, PHR, AMWL, and BMEA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2025Q1 2026
Phreesia, Inc. stock logo
PHR
Phreesia
-$0.13-$0.07+$0.06-$0.07$115.00 million$115.94 million
5/5/2025Q1 2025
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
-$0.84-$0.80+$0.04-$0.80N/AN/A
5/1/2025Q1 2025
American Well Corporation stock logo
AMWL
American Well
-$3.09-$1.73+$1.36-$1.19$60.15 million$66.83 million
3/31/2025Q4 2024
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
-$1.00-$0.81+$0.19-$0.81N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Well Corporation stock logo
AMWL
American Well
N/AN/AN/AN/AN/A
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
N/AN/AN/AN/AN/A
MultiPlan Co. stock logo
MPLN
MultiPlan
N/AN/AN/AN/AN/A
Phreesia, Inc. stock logo
PHR
Phreesia
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Well Corporation stock logo
AMWL
American Well
N/A
2.92
2.89
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
N/A
2.25
2.25
MultiPlan Co. stock logo
MPLN
MultiPlan
21.73
1.05
1.05
Phreesia, Inc. stock logo
PHR
Phreesia
0.02
1.95
1.95

Institutional Ownership

CompanyInstitutional Ownership
American Well Corporation stock logo
AMWL
American Well
56.05%
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
96.72%
MultiPlan Co. stock logo
MPLN
MultiPlan
87.15%
Phreesia, Inc. stock logo
PHR
Phreesia
92.10%

Insider Ownership

CompanyInsider Ownership
American Well Corporation stock logo
AMWL
American Well
11.82%
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
18.42%
MultiPlan Co. stock logo
MPLN
MultiPlan
8.00%
Phreesia, Inc. stock logo
PHR
Phreesia
5.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Well Corporation stock logo
AMWL
American Well
1,04015.61 million13.77 millionOptionable
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
5037.57 million30.65 millionOptionable
MultiPlan Co. stock logo
MPLN
MultiPlan
17016.17 million14.88 millionOptionable
Phreesia, Inc. stock logo
PHR
Phreesia
2,08259.50 million56.23 millionOptionable

Recent News About These Companies

Phreesia Sees RS Rating Improve To 73
Brokerages Set Phreesia, Inc. (NYSE:PHR) Target Price at $31.64
Phreesia, Inc. (NYSE:PHR) Short Interest Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

American Well stock logo

American Well NYSE:AMWL

$7.44 +0.15 (+2.06%)
Closing price 06/25/2025 03:58 PM Eastern
Extended Trading
$7.44 0.00 (0.00%)
As of 06/25/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Biomea Fusion stock logo

Biomea Fusion NASDAQ:BMEA

$1.94 +0.06 (+3.19%)
Closing price 06/25/2025 04:00 PM Eastern
Extended Trading
$1.90 -0.04 (-2.06%)
As of 06/25/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.

MultiPlan stock logo

MultiPlan NYSE:MPLN

$40.56 -0.93 (-2.24%)
As of 06/24/2025

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Phreesia stock logo

Phreesia NYSE:PHR

$27.66 -0.21 (-0.75%)
Closing price 06/25/2025 03:59 PM Eastern
Extended Trading
$27.48 -0.18 (-0.67%)
As of 06/25/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.